China · 
Who invested in Adlai Nortye Biopharma?
Adlai Nortye Biopharma's investors include Matrix, Yuanming Capital, Yahui Precision Medicine and DT.
China · Series B startup
Who invested in Adlai Nortye Biopharma
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Adlai Nortye Biopharma and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$53Mraised across 1 round since 2018, from 1 source
- Latest round
- Series B, $53MJul 2018
- Investors
- 4
The rounds
- Jul 2018
Everyone who backed them
Yahui Precision MedicineGrowth equity1round
DTno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Adlai Nortye Biopharma
How much has Adlai Nortye Biopharma raised?
Adlai Nortye Biopharma has raised $53M across 1 round since 2018.
When did Adlai Nortye Biopharma last raise?
Adlai Nortye Biopharma's most recent round was a Series B of $53M in Jul 2018.
What was Adlai Nortye Biopharma's biggest round?
Its most recent round, $53M in Jul 2018, is also its largest on record.
Who backed Adlai Nortye Biopharma first?
Adlai Nortye Biopharma's first round on record, in Jul 2018, was backed by Matrix, Yuanming Capital and Yahui Precision Medicine and 1 others.
What stage is Adlai Nortye Biopharma at?
Adlai Nortye Biopharma's latest named round is a Series B, in Jul 2018.
Where is Adlai Nortye Biopharma based?
Adlai Nortye Biopharma is based in China.
Companies like Adlai Nortye Biopharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.